GT Biopharma (GTBP) Accumulated Expenses (2010 - 2026)
GT Biopharma's Accumulated Expenses came in at $2.16 million for Q1 2026, up 91.1% from $1.13 million a year earlier and up 38.7% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, GT Biopharma's Accumulated Expenses was $1.56 million, down 13.2% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 3.8% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $1.8 million in FY2024 (+50.4%), $1.2 million in FY2023 (-28.4%), $1.67 million in FY2022 (-12.2%) and $1.9 million in FY2021 (+46.7%).
- The Q1 2026 figure represents the highest quarterly Accumulated Expenses since Q1 2020.
- Year-over-year, Accumulated Expenses increased in four of the last eight quarters, with growth averaging 11.3%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q3 2022 (growth of 105.2%), and the weakest in Q3 2025 (a decline of 78.6%).
- Business Quant data shows GTBP's Accumulated Expenses at $1.56 million (Q4 2025), $400,000 (Q3 2025) and $608,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | GT Biopharma | 8.73 Mn | 8.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 608,000.00 |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 963,000.00 |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 829,000.00 |
| Dec 31, 2022 | 1.67 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 749,000.00 |
| Jun 30, 2021 | 906,000.00 |
API Access
GT Biopharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();